Canadian Health Coalition
  • Donate

    The form is not published.

  • Menu Canvas
    • CHC Home
    • News
    • About us
    • Campaigns
    • Take action
    • Contact
    • Donate
  • hello@healthcoalition.ca
  • 343-558-1788
Donate | Subscribe
    • English
Canadian Health Coalition
  • Home
  • About us
    • Our Team
  • News
  • Campaigns
  • Take action
  • Ways to Give
    • Give one-time
    • Become a monthly donor
    • Leave a gift in your will
    • Make a tribute donation
  • Contact
  • Donate

Canadian Blood Services deal imperils voluntary public blood system and public trust

Homepage Statement Canadian Blood Services deal imperils voluntary public blood system and public trust
Statement

Canadian Blood Services deal imperils voluntary public blood system and public trust

September 6, 2022
By Anne Lagacé Dowson
0 Comment
1842 Views

The Canadian Blood Services has announced an agreement with Grifols, a huge for-profit international plasma company to undertake, on CBS’s behalf, that which CBS has always denied it would do: pay Canadians for plasma.

The Canadian Health Coalition denounces this decision and the secrecy surrounding it. Plasma is a voluntarily donated public resource that can be manufactured into plasma products that are ounce-for-ounce worth more than gold. 

“This decision of the Canadian Blood Services Board reflects irresponsible stewardship of our public blood supply system, allowing commercialization on a massive scale,” says Pauline Worsfold, RN, and chair of the Canadian Health Coalition. “The failure of CBS to uphold its mandate to operate a voluntary public blood supply system is unacceptable.”

The Canadian Health Coalition fears the impending deal lacks legislated limits to protect the sustainability of the public system from encroachment by large-scale commercialization. 

In the CBS’s own words:

 “A small number of commercial collection sites are not likely to have a negative effect on the national blood system supply chain. However, large-scale commercial growth—without appropriate controls—could encroach on the existing system for both blood and plasma collections.”

“Withholding public information on this major decision on managing a crucial public resource betrays public trust. Whether done by CBS or by their commercial agent, paying Canadians for plasma on this massive scale will imperil voluntary blood collection. The lack of open public dialogue prior to CBS’s final decision is a disgraceful betrayal of public trust,” says Dr. Michèle Brill-Edwards, former Health Canada regulator and Canadian Health Coalition board member.

Many options to improve voluntary plasma self-sufficiency are being used successfully by other countries such as Australia and France. Héma-Québec, the equivalent of CBS in Québec, has doubled self-sufficiency from 15% to 30% between 2016 and 2021, while CBS remained at 15% in the same time frame.

The damage done by such a deal goes well beyond the unacceptable decision to pay Canadians for their plasma. The secrecy and duplicity behind this deal undermine trust in the Canadian Blood Services itself. 

Health Ministers are collectively responsible for faithful implementation of their 1998 agreement which created the Canadian Blood Services in the wake of the tainted blood scandal. Canadian Blood Services is a public agency entrusted to operate Canada’s voluntary blood supply system, other than in Quebec, with the safety of Canadians in mind. 

The Canadian Health Coalition calls on the ministers to recommit to the voluntary public mandate of the Canadian Blood Services by dismissing the current CEO and Board of CBS, and installing new Directors and CEO to faithfully implement the 1998 agreement protecting the safety of Canadians. Restoring public trust via new leadership is vital to the operation of our voluntary public blood supply.

This article has been updated from a previous version to reflect the announcement made by Canadian Blood Services on Wednesday September 7, 2022, that it has reached an agreement with Grifols.

Stay in the loop—subscribe to our newsletter and follow us on social media for the latest updates on public health care in Canada

  • Facebook
  • Instagram
  • TikTok
  • Bluesky
  • X
  • LinkedIn

    Tags: Plasma

    Previous Story
    Webinar: Pharma profits or health justice?
    Next Story
    Canadian Blood Services is betraying the public trust

    Related Articles

    Eyes on Ontario after BC slams door on for-profit plasma collection

    Will Ontario enforce its paid plasma ban and keep Grifols...

    Taking health care to the streets in December

    Watch for more public health care actions in 2023

    Recent Posts

    • Meet your new minister of health: Marjorie Michel May 14, 2025
    • Without mental health and substance use care, Canada’s health care system is not universal May 13, 2025
    • Study says private clinics are selling patient data to big pharma May 13, 2025
    • Carney to announce new health minister next week May 7, 2025
    • Pharmacare must expand as Trump’s tariffs threaten prescription drug access in Canada May 7, 2025

    Tags

    Canada Health Act Canada Health Transfer Canadian Health Coalition COVID-19 Dental Care Federal Election 44 Federal Election 45 Health+Hope 2025 Health Care Workers Health Policy Home care Long-term Care Medicare Mental Health Pharmacare Plasma Privatization Racism Reproductive Health Care Sexual and reproductive health and rights Solutions series Substance use care Toxic drug crisis
    Canadian Health Coalition
    2841 Riverside Dr.
    Ottawa, Ontario K1V 8X7
    +343.558.1788
    hello@healthcoalition.ca
    • Home
    • What we do
    • Campaigns
    • News
    • Contact
    SearchPostsLogin
    Wednesday, 14, May
    Meet your new minister of health: Marjorie Michel
    Tuesday, 13, May
    Without mental health and substance use care, Canada’s health care system is not universal
    Tuesday, 13, May
    Study says private clinics are selling patient data to big pharma
    Wednesday, 7, May
    Carney to announce new health minister next week
    Wednesday, 7, May
    Pharmacare must expand as Trump’s tariffs threaten prescription drug access in Canada
    Tuesday, 6, May
    Research roundtable to examine Canada’s health care profitization problem

    Welcome back,